Virax Biolabs Group Ltd - Ordinary Shares - Class A

NASDAQ:VRAX   3:59:27 PM EDT
0.92
+0.05 (+5.86%)
7:30:41 PM EDT: $0.92 0.00 (-0.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.00M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.01 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$0.89
50-Day MA$0.94
200-Day MA$1.52
See more pivots

Virax Biolabs Group Ltd - Ordinary Shares - Class A Stock, NASDAQ:VRAX

Bo'Ness Road Newhouse, Lanarkshire, Scotland ML1 5UH
United Kingdom
Phone: +44.20.7788.7414
Number of Employees: 17

Description

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.